| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |